Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC+RT vs IC+CCRT in LA-NPC
NCT04414566Phase 3Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, gemcitabine, docetaxel, fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
cisplatingemcitabinedocetaxelfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04414566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414566.